Filing Details

Accession Number:
0001192482-13-000245
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-19 12:54:29
Reporting Period:
2013-12-17
Filing Date:
2013-12-19
Accepted Time:
2013-12-19 12:54:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1361248 Tetralogic Pharmaceuticals Corp TLOG Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1590862 A. Peter Meyers C/O Tetralogic Pharmaceuticals Corp
343 Phoenixville Pike
Malvern PA 19355
Cfo & Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-12-17 142,857 $7.00 142,857 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Acquisiton 2013-12-17 164,394 $7.00 164,394 $7.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
487,888 2023-12-17 No 4 A Direct
Footnotes
  1. Twenty-five percent (25%) of the options or 41,098 options vested at the closing of the Company's initial public offering on 12/17/13; the balance of the options become exercisable at the rate of 3,424 options per month until all of the options are vested with 3,456 vested in the final month. Vesting ceases if the employee is no longer an active full-time employee of the Company on the vesting date. If there is a change of control as defined in the Company's 2013 Equity Plan, the entire unvested portion of the shares shall become immediately vested.